Farms.com Home   Farm Equipment News

CNH Invests in Ecofriendly Bale Storage Innovator Nature’s Net Wrap

CNH Industrial, through its investment arm CNH Ventures, announced Jan. 23 it is supporting the scientific development of the first viable compostable net wrap for bales in agriculture through an investment in Canadian start-up Nature’s Net Wrap.

The compostable net wraps aim to reduce landfill use, haulage and disposal costs, eliminate soil contamination, improve animal safety and reduce the risk of water contamination, resulting in a reduction of approximately 2.5 million tons of plastic waste per year. High growth in this market is propelled by the general demand for chemical- and plastic-free solutions. Initial product launch is expected in 2024.

This solution uses biopolymer material made from renewable resources. It holds up structurally and can either naturally break down in the earth’s soil or be composted. CNH Industrial's investment is supporting the testing and validation of the solution, with a New Holland baler producing all the bales in this testing phase.

Source : Farm Equipment

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.